Search Results 501-510 of 17265 for SC

  1. Evanthia Galanis, M.D. - Mayo Clinic Faculty Profiles

    D.Sc - ""Development and application of quantitative immunoenzymatic assays (ELISAS) and immunoblotting techniques in the study of specificity and title of ...

  2. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to assess the pharmacodynamics (PD) of HM15211 after administration of multiple subcutaneous (SC) doses compared to placebo on ...

  3. Epigenomics and Spatial Biology Core - Mayo Clinic Research

    Single cell (sc) ATAC-seq. Single-cell ATAC-seq combined with gene expression (scATAC+GEX). Single-cell GEX Flex, a single-cell transcriptome assay for ...

  4. Publications - Dawn Owen, M.D., Ph.D. - Mayo Clinic

    ... SC, Park SS, Deufel CL, Kavanaugh JA, Grams MP. Highs and Lows of Spatially Fractionated Radiation Therapy: Dosimetry and Clinical Outcomes. Pract Radiat ...

  5. Internal Medicine Residency (Florida) - Meet Our Residents

    Coral Holt, M.D.. Hometown: Myrtle Beach, SC. Medical School: University of South Carolina School of Medicine Greenville. About me: Growing up at the beach, I ...

  6. Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis - Mayo Clinic

    ... (SC) low-molecular-weight heparin (LMWH), monitored IV, or SC unfractionated heparin (UFH), unmonitored weight-based SC UFH, or SC fondaparinux (all Grade 1A).

  7. Nonalcoholic Steatohepatitis (NASH) Clinical Trials - Mayo Clinic Research

    ... (sc) to adult subjects with suspected or confirmed diagnosis of noncirrhotic nonalcoholic steatohepatitis (NASH) with no fibrosis to moderate fibrosis ...

  8. Publications - Dimitar K. Gavrilov, M.D., Ph.D. - Mayo Clinic

    ... SC. Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone ... SC, Caggana M, Bryant SC, Caldwell SG, Camilot M, Campbell C, Carducci C ...

  9. Dose Ranging Study Of Lunsekimig Compared With Placebo-control In Adult Participants With Moderate-to-severe Asthma - Mayo Clinic

    ... SC lunsekimig in adult participants aged 18 to 80 years, (inclusive) with moderate-to-severe asthma. Participation eligibility. Participant eligibility ...

  10. A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis - Mayo Clinic

    The purpose of this randomized, double-blind study is to investigate the efficacy and safety of mepolizumab (300 milligram [mg] administered subcutaneously [SC] ...